retatrutide clinical trial outcomes Weight loss with as compared to currently licenced obesity Retatrutide, an experimental drug currently
Description
The medication is injected subcutaneously once a week
Gastroenterology 2002;123:11208
doi: 10.1016/s2213-8587(17)30412-6 [DOI] [PubMed] [Google Scholar] 6
Gupta S
In addition, several studies are exploring the effects of GLP-1 RAs on patients
